Product Information
FENOFIBRATE 145 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.1214 per EA under NDC 69097045805. Its NADAC has been published 493 times since Mar 15, 2017.
FDA first approved this application on Dec 15, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
145 mg/1
Manufacturer
Cipla USA Inc.NDC
69097045805
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
FENOFIBRATEApproval Type
Generic (ANDA)
FDA Application
ANDA208709FDA Approved
12/15/2016
TE Code
AB
On Market Since
12/15/2016
Pharmacological Classes
Price Statistics
The NADAC for FENOFIBRATE 145 MG TABLET has been published 493 times since Mar 15, 2017, and over the history we have for it it has declined 81.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1214 per EA |
|---|---|
| All-time high | $0.6452 (Mar 15, 2017) |
| All-time low | $0.1088 (Nov 20, 2024) |
| 52-week high | $0.1214 |
| 52-week low | $0.1130 |
| Median price | $0.1878 |
| Average price | $0.2194 |
| Largest weekly change | +29.9% (Sep 23, 2020) |
| Weeks tracked | 493 |
| Tracking since | Mar 15, 2017 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of FENOFIBRATE 145 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FENOFIBRATE 145 MG TABLET, manufactured by Cipla USA Inc., is $0.1214 per EA (NDC 69097045805), effective Aug 19, 2026.
How has the price of FENOFIBRATE 145 MG TABLET changed over time?
Over the history we have for it, the NADAC for FENOFIBRATE 145 MG TABLET has declined 81.2%. It has been tracked across 493 weekly CMS publications since Mar 15, 2017.
What are the highest and lowest recorded NADAC prices for FENOFIBRATE 145 MG TABLET?
Since Mar 15, 2017, the NADAC for FENOFIBRATE 145 MG TABLET has ranged from a low of $0.1088 (Nov 20, 2024) to a high of $0.6452 (Mar 15, 2017), with a median of $0.1878 per EA.
Are there cheaper alternatives to FENOFIBRATE 145 MG TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FENOFIBRATE 145 MG TABLET, is $0.1198 per EA — about 1% below FENOFIBRATE 145 MG TABLET.
Who manufactures FENOFIBRATE 145 MG TABLET?
FENOFIBRATE 145 MG TABLET (NDC 69097045805) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.